Evidence-Based Ethics for Neurology and Psychiatry Research

NeuroRx

Volumn 1, Issue 3, 2004, Pages 372-377

  Kim, Scott Y H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

conflicts of interest; informed consent; neurotherapeutics; Research ethics; risk benefit analysis

Indexed keywords

ARTICLE; BIOETHICS; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INTERVENTION STUDY; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; PHILOSOPHY; RISK BENEFIT ANALYSIS; THEOLOGY; TREATMENT PLANNING; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFLICT OF INTEREST; ETHICS; INFORMED CONSENT; MENTAL HEALTH THERAPIES; NEUROLOGY; NEUROPSYCHOLOGY; PSYCHIATRY; REVIEW; RISK ASSESSMENT;

BIOMEDICAL AND BEHAVIORAL RESEARCH; MENTAL HEALTH THERAPIES;

BIOETHICAL ISSUES; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; HUMANS; INFORMED CONSENT; NEUROLOGY; NEUROPSYCHOLOGY; PSYCHIATRY; RISK ASSESSMENT;

EID: 23844451779     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.1.3.372     Document Type: Article

References (66)

1. Orgogozo J., Gilman S., Dartigues J., Laurent B., Puel M., Kirby L., et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 61 (2003) 46-54
2. Silverberg G., Levinthal E., Sullivan E., Bloch D., Chang S., Leverenz J., et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 59 (2002) 1139-1145
3. Hock C., Konietzko U., Streffer J., Tracy J., Signorell A., Muller-Tillmanns B., et al. Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38 (2003) 547-554
4. Kim S., Caine E., Currier G., Leibovici A., and Ryan J. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry 158 (2001) 712-717
5. Carpenter Jr. W., Gold J., Lahti A., Queern C., Conley R., Bartko J., et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 57 (2000) 533-538
6. National Bioethics Advisory Commission. Research involving persons with mental disorders that may affect decision making capacity, Vol 1, report and recommendations of the National Bioethics Advisory Commission (1998), NBAC, Rockville, MD
7. Neuroethics: mapping the field: conference proceedings May 13-14. 2002, San Franciso, California. In: Marcus S. (Ed) (2002), The Dana Press, New York
8. Jonsen A. The birth of bioethics (1998), Oxford University Press, New York
9. Stolberg S. The biotech death of Jesse Gelsinger. N Y Times Mag Nov 28 (1999) 136-140 149-150
10. Kolata G. Johns Hopkins Death Brings Halt to U. S.-financed human studies. N Y Times Mag Jul 20 (2001) A1 A18
11. Marshall E. Shutdown of research at Duke sends a message. Science 284 (1999)
12. National Institutes of Health. Required education in the protection of human research participants. NOTICE: OD-00-039, June 5,2000.
13. Association for the Accreditation of Human Research Protection Programs Inc. AAHRPP website,2002.
14. Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress-policy and guidelines for the oversight of individual financial interest in human subjects research (2001), Association of American Medical Colleges
15. Task Force on Research Accountability. Report on individual and institutional financial conflict of interest (2001), Association of American Universities
16. Wilson D., and Heath D. Class-action suit filed against 'The Hutch'. Seattle Times Mar 27 (2001)
17. Mello M., Studdert D., and Brennan T. The rise of litigation in human subjects research. Ann Intern Med 139 (2003) 40-45
18. Emanuel E., Wendler D., and Grady C. What makes clinical research ethical?. JAMA 283 (2000) 2701-2711
19. Blumenthal D. Ethics issues in academic-industry relationships in the life sciences: the continuing debate. Acad Med 71 (1996) 1291-1296
20. Emanuel E., and Steiner D. Institutional conflict of interest. N Engl J Med 332 (1995) 262-267
21. Frankel M. Perception, reality, and the political context of conflict of interest in university-industry relationships. Acad Med 71 (1996) 1297-1304
22. Munro N. Doctor Who?. Washington Monthly Nov (2002)
23. Karlawish J. The search for a coherent language: the science and politics of drug testing and approval. In: Kapp M. (Ed). Ethics, law, and aging review, Vol 8, Issues in conducting research with and about older persons (2002), Springer, New York 39-56
24. Bekelman J., Li Y., and Gross C. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454
25. Nathan D., and Weatherall D. Academic freedom in clinical research. N Engl J Med 347 (2002) 1368-1371
26. Shuchman M. Legal issues surrounding privately funded research cause furore in Toronto. CMAJ 159 (1998) 983-986
27. Rennie D. Thyroid storm. JAMA 277 (1997) 1238-1243
28. Stelfox H., Chua G., O'Rourke K., and Detsky A. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338 (1998) 101-106
29. Levine J., Gussow J., Hastings D., and Eccher A. Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health 93 (2003) 664
30. Pieters T. Marketing medicines through randomised controlled trials: the case of interferon. Br Med J 317 (1998) 1231-1233
31. Blumenthal D. Academic-industry relationships in the life sciences. Extent, consequences, and management. JAMA 268 (1992) 3344-3349
32. Safer D. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 190 (2002) 583-592
33. Baker C., Johnsrud M., Crismon M., Rosenheck R., and Woods S. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 183 (2003) 498-506
34. Libby R., Bloomfield R., and Nelson M. Experimental research in financial accounting. Accounting, Organizations and Society 27 (2002) 775-810
35. Bazerman M., Loewenstein G., and Moore D. Why good accountants do bad audits. Harv Bus Rev 80 (2002) 96-102 134
36. Messick D., and Bazerman M. Ethical leadership and the psychology of decision making. Sloan Manage Rev 37 (1996) 9-22
37. Dana J., and Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 290 (2003) 252
38. Sugarman J., Faden R., and Weinstein J. A decade of empirical research in medical ethics. In: Sugarman J., and Sulmasy D. (Eds). Methods in medical ethics (2001), Georgetown University Press, Washington, DC 19-28
39. Weijer C. Thinking clearly about research risk: implications of the work of Benjamin Freedman. IRB 21 (1999) 1-5
40. Keyserlingk E. Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 38 (1995) 319-362
41. Meslin E., Lavery J., Sutherland H., and Till J. Judging the ethical merit of clinical trials: what criteria do research ethics board members use?. IRB 16 (1994) 6-10
42. Sunderland T., Linker G., Mirza N., Putnam K., Friedman D., Kimmel L., et al. Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289 (2003) 2094-2103
43. Kim S., Appelbaum P., Jeste D., and Olin J. Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations. Am J Psychiatry 161 (2004) 797-806
44. Macklin R. The ethical problems with sham surgery in clinical research. N Engl J Med 341 (1999) 992-996
45. Weijer C. I need a placebo like I need a hole in the head. J Law Med Ethics 30 (2002) 69-72
46. Albin R. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. J Med Ethics 28 (2002) 322-325
47. Grady D., and Kolata G. Gene therapy used to treat patients with Parkinson's. N Y Times Mag (Aug 19, 2003)
48. Miller M. Phase I oncology trials. In: Amdur R., and Bankert E. (Eds). Institutional review board: management and function (2002), Jones and Bartlett, Sudbury, Massachusetts 465-475
49. Wendler D., Martinez R., Fairclough D., Sunderland T., and Emanuel E. Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. Am J Psychiatry 159 (2002) 585-591
50. Janofsky J., and Starfield B. Assessment of risk in research on children. J Pediatr 98 (1981) 842-846
51. Payne J., Bettman J., and Schkade D. Measuring constructed preferences: toward a building code. J Risk Uncertain 19 (1999) 243-270
52. Fischhoff B. Cognitive processes in stated preference methods. In: Mäler K.-G., and Vincent J. (Eds). Handbook of environmental economics (2002), Elsevier, North-Holland
53. Abelson J., Forest P., Eyles J., Smith P., Martin E., and Gauvin F. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med 57 (2003) 239-251
54. Gutmann A., and Thompson D. Deliberating about bioethics. Hastings Cent Rep 27 (1997) 38-41
55. Gutmann A., and Thompson D. Democracy and disagreement (1996), Harvard University Press, Cambridge, MA
56. Nelson R. Voluntariness of consent for research: an empirical and conceptual review. Med Care 40 Suppl 9 (2002) V69-V80
57. Roberts L. Informed consent and the capacity for voluntarism. Am J Psychiatry 159 (2002) 705-712
58. Kim S., Karlawish J., and Caine E. Current state of research on decision-making competence of cognitively impaired elderly persons. Am J Geriatr Psychiatry 10 (2002) 151-165
59. Appelbaum P., Grisso T., Frank E., O'Donnell S., and Kupfer D. Competence of depressed patients for consent to research. Am J Psychiatry 156 (1999) 1380-1384
60. Dymek M., Atchison P., Harrell L., and Marson D. Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 56 (2001) 17-24
61. Moser D., Schultz S., Arndt S., Benjamin M., Fleming F., Brems C., et al. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry 159 (2002) 1201-1207
62. Dunn L., Lindamer L., Palmer B., Schneiderman L., and Jeste D. Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry 158 (2001) 1911-1913
63. Wirshing D., Wirshing W., Marder S., Liberman R., and Mintz J. Informed consent: assessment of comprehension. Am J Psychiatry 155 (1998) 1508-1511
64. Marson D., Ingram K., Cody H., and Harrell L. Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Arch Neurol 52 (1995) 949-954
65. Kim S., and Caine E. Utility and limits of the mini mental state examination in evaluating consent capacity in Alzheimer's disease. Psychiatr Serv 53 (2002) 1322-1324
66. Mezey M., Teresi J., Ramsey G., Mitty E., and Bobrowitz T. Decision-making capacity to execute a health care proxy: development and testing of guidelines. J Am Geriatr Soc 48 (2000) 179-187